Better

Medical-grade Cannabis

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in August 2009 by Yohai Golan-Gild, Better operates with 11–50 employees. The company has raised $15 million across one funding round from Narin Niruttinanon. In February 2022, InterCure signed a definitive agreement to acquire the multi-national medical cannabis producer.

Business overview

Better specializes in the development of medical-grade cannabis for various medical conditions, focusing on strains with diverse CBD and THC combinations and high terpene levels to enhance product efficiency and potency. The company offers a range of products tailored to specific medical needs, ensuring standardized and stable natural medicine grown by experienced professionals. Better's contaminant-free products are guaranteed to contain consistent levels of active pharmaceutical ingredients, including THC, CBD, and other cannabinoids. The company has developed eight unique strains, with more in development, providing a wide array of cannabinoid and terpene combinations to address a broad spectrum of conditions. Better operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Medical Cannabis, serving the healthcare industry and patients globally, including Australia.

Strategic signal

In February 2022, InterCure signed a definitive agreement to acquire Better. This acquisition signals a significant consolidation within the medical cannabis industry, indicating strategic moves by larger players to expand their market share and product portfolios through the integration of established medical-grade cannabis producers like Better. For investors, this highlights the ongoing M&A activity and potential for exits in the rapidly evolving medical cannabis sector.

Log in to access full profile

Company Intelligence Q&A

What was a significant corporate development for Better in early 2022?
In February 2022, InterCure signed a definitive agreement to acquire Better, a multi-national medical cannabis producer.
When did Better Holdings express interest in selling its Israeli operations?
In October 2019, Cannabis Company Better Holdings indicated its intention to sell its Israeli operations.
Who was identified as an investor in Better in June 2020?
In June 2020, Thai businessman Narin Niruttinanon was identified as an investor in the Israeli cannabis company Better.
What was the focus of Better's founder in advancing medicinal marijuana research?
In September 2016, Better Founder Yohai Gild Golan was noted for advancing medicinal marijuana research in Israel.
What medical cannabis trial was announced in June 2016 involving the University of Canberra?
In June 2016, medical cannabis was announced to be trialled in the treatment of melanoma at the University of Canberra.
Log in to access full profile